Oxford Index Browse

You are looking at 1-10 of 44 items for:

Pharmacology x Rheumatology x clear all

Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis

Michael Bonelli, Lisa Göschl, Stephan Blüml, Thomas Karonitsch, Kiyoshi Hirahara, Elisabeth Ferner, Carl-Walter Steiner, Günter Steiner, Josef S. Smolen and Clemens Scheinecker.

in Rheumatology

April 2016; p ublished online December 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 5526 words.

Objective. Abatacept (CTLA-4Ig) blocks CD28-mediated T cell activation by binding to the costimulatory B7 ligands CD80/CD86 on antigen presenting cells. Costimulatory...

Go to Oxford Journals »  home page

Biologic efficacy optimization—a step towards personalized medicine

Patrick D. W. Kiely.

in Rheumatology

May 2016; p ublished online September 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 6147 words.

This following is a review of the factors that influence the outcome of biologic agents in the treatment of adult RA and, when synthesized into the clinical decision-making process, enhance...

Go to Oxford Journals »  home page

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids

Julia Flint, Sonia Panchal, Alice Hurrell, Maud van de Venne, Mary Gayed, Karen Schreiber, Subha Arthanari, Joel Cunningham, Lucy Flanders, Louise Moore, Amy Crossley, Neetha Purushotham, Amisha Desai, Madeleine Piper, Mohamed Nisar, Munther Khamashta, David Williams, Caroline Gordon and Ian Giles.

in Rheumatology

September 2016; p ublished online January 2016 .

Journal Article. Subjects: Pharmacology; Rheumatology; Obstetrics. 2259 words.

Go to Oxford Journals »  home page

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice

Julia Flint, Sonia Panchal, Alice Hurrell, Maud van de Venne, Mary Gayed, Karen Schreiber, Subha Arthanari, Joel Cunningham, Lucy Flanders, Louise Moore, Amy Crossley, Neetha Purushotham, Amisha Desai, Madeleine Piper, Mohamed Nisar, Munther Khamashta, David Williams, Caroline Gordon and Ian Giles.

in Rheumatology

September 2016; p ublished online January 2016 .

Journal Article. Subjects: Rheumatology; Obstetrics; Pharmacology. 2377 words.

Go to Oxford Journals »  home page

Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants

José Inciarte-Mundo, Virginia Ruiz-Esquide, Maria Victoria Hernández, Juan D. Cañete, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Jordi Yagüe and Raimon Sanmarti.

in Rheumatology

December 2015; p ublished online August 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 2579 words.

Objective. To compare the accuracy of serum calprotectin levels, CRP and ESR in stratifying disease activity in RA patients receiving tocilizumab (TCZ).

M...

Go to Oxford Journals »  home page

Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom

Andrew Judge, Gemma Wallace, Dani Prieto-Alhambra, Nigel K. Arden and Christopher J. Edwards.

in Rheumatology

December 2015; p ublished online August 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 2741 words.

Objective. To assess whether publication of national treatment guidelines improved the management of early RA in the UK.

Methods. Incident diagnoses of RA...

Go to Oxford Journals »  home page

Cardiovascular risk with NSAIDs in rheumatoid arthritis: an analysis using routinely collected data

Antigoni Grigoriou, Fowzia Ibrahim, Khaldoun Chaabo, David L Scott, Sophia Steer and James Galloway.

in Rheumatology

April 2016; p ublished online November 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 1049 words.

Go to Oxford Journals »  home page

Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?

Max Yates, Andrew Keat and Karl Gaffney.

in Rheumatology

May 2016; p ublished online December 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 2035 words.

Go to Oxford Journals »  home page

Drug trough levels predict therapeutic responses to dose reduction of adalimumab for rheumatoid arthritis patients during 24 weeks of follow-up

Der-Yuan Chen, Yi-Ming Chen, Tsu-Yi Hsieh, Wei-Ting Hung, Chia-Wei Hsieh, Hsin-Hua Chen, Kuo-Tung Tang and Joung-Liang Lan.

in Rheumatology

January 2016; p ublished online August 2015 .

Journal Article. Subjects: Rheumatology; Pharmacology. 3039 words.

Objective. To evaluate the impact of adalimumab (ADA) dose-halving on therapeutic responses and drug levels, the differences in drug levels among patients with different...

Go to Oxford Journals »  home page

Drugs used in rheumatology

Alan J. Hakim, Gavin P.R. Clunie and Inam Haq.

in Oxford Handbook of Rheumatology

P ublished online September 2011 .

Chapter. Subjects: Rheumatology; Pharmacology. 11891 words.

Introduction - Principles of rehabilitation - Pain relief - Opioid analgesics - Non-steroidal anti-inflammatory drugs - Antidepressants - Anticonvulsants - Glucocorticoids - (Non-biologic)...

Go to Oxford Medicine Online »  abstract